Trade Therapy

Page 93

Trade Policies in Medical Goods and Services

Figure 2.7 Government support measures for the medical goods sector predated the pandemic

Number of interventions

700

16

600

59

500

5

400

13 42

300 200 100 0

45 68

5 34 86

2009

2010

6 36

3 49

4 37

1 42

98

106

145

152

2011

2012

2013

2014

305

2015

58 8 3 40

14 10

107

193

195

212

2016

2017

2018

545 8 10

389

156 2019

2020

2021

Localization measures (except public procurement localization) Public procurement measures (including public procurement localization) Inward subsidies

Source: Global Trade Alert (GTA) database, https://www.globaltradealert.org/data_extraction. Note: The government support measures represent a total of 156 economies (across all income groups) tracked by GTA data between 2009 and 2021.

provide information on the impact of measures) found to favor local firms in the medical goods sector (figure 2.7). A total of 3,305 instances of such government support measures have been recorded in a total of 156 economies from 2009 through 2021, all of which have been implemented. Of that total, 2,650 are subsidies to commercial medical goods operators. In addition, 569 changes to public procurement regulations or laws favor local suppliers of medical goods. As figure 2.7 also shows, the number of government support measures was rising in the years before the COVID-19 pandemic. Then more than 600 instances of government support measures using these three policy instruments were recorded in 2020. The number of subsidies awarded to producers of medical goods has been on the rise since the 2008–09 Global Financial Crisis. The three-year moving average rises from 84 for the years 2009–11 to 265 in the three years before the pandemic (2017–19) and rises further to 350 (for the years 2020–21). To put this fourfold increase in perspective, consider the following: over the same period (2009–21), the total number of subsidies in all sectors recorded each year in the GTA database rose by just under 150 percent. The faster growth in recorded subsidies to the medical sector is not a pandemic-era ­phenomenon; annual subsidy awards rose by 71 percent across all sectors of the economy before the pandemic, whereas they more than tripled in the medical sector.

Government procurement The introduction of competitive and transparent government procurement procedures holds the potential to contribute substantially to improving the accessibility and

77


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

response for future pandemics

18min
pages 177-187

Notes

11min
pages 165-168

References

12min
pages 169-174

3.2 Low levels of GATS commitments in medical services trade

1min
page 147

commitments than in GATS

15min
pages 148-154

Cooperation beyond trade agreements for global health security

22min
pages 155-164

3.3 Potential commitments to bolster governance of trade policy in global crises

20min
pages 131-139

Trade policy cooperation to contribute to global health security

3min
pages 127-128

3.5 Traceability and illicit trade in medical products in Africa

5min
pages 145-146

B3.4.2 Types of health technology transfer programs reported by WTO developed country members under TRIPS Agreement, art. 66.2, 2018–20

5min
pages 142-144

3.2 Pricing policies for medical goods in the context of international trade

6min
pages 124-126

3.1 RTA cooperation during the COVID-19 pandemic

6min
pages 121-123

References

12min
pages 114-118

Policies affecting medical goods and services trade during the COVID-19 pandemic

2min
page 96

the onset of the COVID-19 pandemic (excluding China), January 2020 to March 2022

5min
pages 108-110

Notes

8min
pages 111-113

2.11 NRA decisions on WHO-EUL COVID-19 vaccines, December 2020 to February 2022

8min
pages 104-107

2.7 Government support measures for the medical goods sector predated the pandemic

6min
pages 93-95

2.4 Trade in medical services faces many trade barriers

5min
pages 88-90

References

8min
pages 71-74

2.2 WTO-notified quantitative restrictions, by type and member income group, 2018–19

3min
pages 80-81

2.3 Progress on implementation commitments under the WTO Trade Facilitation Agreement

10min
pages 82-86

1.22 The vaccine value chains

3min
pages 68-69

2.2 Development of export-oriented medical services in selected countries

2min
page 87

1.17 Exports of PPE soared early in the COVID-19 pandemic

0
page 63

Notes

2min
page 70

1.11 Trade in medical services hit US$78.6 billion in 2019

1min
page 56

1.3 Recent FDI trends in medical goods and services

2min
page 46

Personnel—and the blurred boundaries between trade in medical services and migration of health workers

5min
pages 43-44

1.6 MNCs’ contribution to global value added and exports varies by industry

3min
pages 50-51

Patterns in medical goods and services trade before the pandemic

2min
page 52

B1.1.1 Private health insurance schemes as a share of total health expenditure in selected countries, 2019

3min
pages 41-42

1.1 Access to health care: The role of (trade in) health insurance services

2min
page 40

Drivers of trade in medical goods and services

2min
page 36

of medical goods and services, leading to concentration

8min
pages 32-35

Notes

1min
page 23

1 Trade and trade-related policy actions to improve prevention, preparedness, and

2min
page 20

Deepening cooperation on medical goods and services trade

4min
pages 21-22

Stronger trade systems for better global health security

1min
page 25

References

1min
page 24

Organization of the report

1min
page 26

Reference

0
pages 27-28

The medical goods and services trade: Relevance, characteristics, and welfare implications

1min
page 29
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.